Lilly aims to leapfrog rivals with cluster headache approval
US FDA approves Eli Lilly’s Emgality for episodic cluster headaches, putting it ahead of its rivals in the CGRP space.
Archives for June 5, 2019
Centrifuge to enable scalability launched through Thermo Fisher partnership
Thermo Fisher and Scinogy partner to improve scalability and cost-effectiveness of cell and gene therapy manufacture through the addition of the former’s centrifuge.